138 related articles for article (PubMed ID: 3275475)
1. Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma.
Selvanayagam P; Blick M; Narni F; van Tuinen P; Ledbetter DH; Alexanian R; Saunders GF; Barlogie B
Blood; 1988 Jan; 71(1):30-5. PubMed ID: 3275475
[TBL] [Abstract][Full Text] [Related]
2. Elevated c-myc messenger RNA in multiple myeloma cell lines.
Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
[TBL] [Abstract][Full Text] [Related]
3. Expression of myc-family genes in established human multiple myeloma cell lines: L-myc but not c-myc gene expression in the U-266 myeloma cell line.
Jernberg-Wiklund H; Pettersson M; Larsson LG; Anton R; Nilsson K
Int J Cancer; 1992 Apr; 51(1):116-23. PubMed ID: 1563831
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
5. The 5T mouse multiple myeloma model: absence of c-myc oncogene rearrangement in early transplant generations.
Radl J; Punt YA; van den Enden-Vieveen MH; Bentvelzen PA; Bakkus MH; van den Akker TW; Benner R
Br J Cancer; 1990 Feb; 61(2):276-8. PubMed ID: 2310679
[TBL] [Abstract][Full Text] [Related]
6. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
Bauer SR; Piechaczyk M; Nordan RP; Owens JD; Nepveu A; Marcu KB; Mushinski JF
Oncogene; 1989 May; 4(5):615-23. PubMed ID: 2657576
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells.
Nobuyoshi M; Kawano M; Tanaka H; Ishikawa H; Tanabe O; Iwato K; Asaoku H; Sakai A; Kuramoto A
Br J Haematol; 1991 Apr; 77(4):523-8. PubMed ID: 2025578
[TBL] [Abstract][Full Text] [Related]
8. Altered c-myc RNA metabolism in Burkitt's lymphomas and mouse plasmacytomas.
Piechaczyk M; Bonnieu A; Eick D; Remmers E; Yang JQ; Marcu K; Jeanteur P; Blanchard JM
Curr Top Microbiol Immunol; 1986; 132():331-8. PubMed ID: 3024921
[No Abstract] [Full Text] [Related]
9. c-myc overexpression is not mandatory in aggressive-phase multiple myeloma with Burkitt's type translocation.
Kuroda J; Kimura S; Akaogi T; Hayashi H; Nishida K; Taniwaki M; Kashima K; Abe T; Kobayashi Y; Kondo M
Ann Hematol; 2000 Sep; 79(9):514-8. PubMed ID: 11043423
[TBL] [Abstract][Full Text] [Related]
10. Amplification of the c-myc and the pvt-like region in human multiple myeloma.
Bakkus MH; Brakel-van Peer KM; Michiels JJ; van 't Veer MB; Benner R
Oncogene; 1990 Sep; 5(9):1359-64. PubMed ID: 2216459
[TBL] [Abstract][Full Text] [Related]
11. Biology of the lymphomas: cytogenetics, molecular biology, and virology.
Ambinder RF; Griffin CA
Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167
[TBL] [Abstract][Full Text] [Related]
12. Normal expression of a rearranged and mutated c-myc oncogene after transfection into fibroblasts.
Richman A; Hayday A
Science; 1989 Oct; 246(4929):494-7. PubMed ID: 2683072
[TBL] [Abstract][Full Text] [Related]
13. A novel type of c-myc translocation in a T lymphoma cell line.
Aghib D; Ottolenghi S; Rocchi M; Guerrasio A; Saglio G
Ann N Y Acad Sci; 1987; 511():338-42. PubMed ID: 3326469
[No Abstract] [Full Text] [Related]
14. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
Avet-Loiseau H; Gerson F; Magrangeas F; Minvielle S; Harousseau JL; Bataille R;
Blood; 2001 Nov; 98(10):3082-6. PubMed ID: 11698294
[TBL] [Abstract][Full Text] [Related]
15. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
16. Ras oncogene mutation in multiple myeloma.
Neri A; Murphy JP; Cro L; Ferrero D; Tarella C; Baldini L; Dalla-Favera R
J Exp Med; 1989 Nov; 170(5):1715-25. PubMed ID: 2681517
[TBL] [Abstract][Full Text] [Related]
17. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
18. Human small-cell lung cancers show amplification and expression of the N-myc gene.
Nau MM; Brooks BJ; Carney DN; Gazdar AF; Battey JF; Sausville EA; Minna JD
Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1092-6. PubMed ID: 2869482
[TBL] [Abstract][Full Text] [Related]
19. Localization of breakpoints by polymerase chain reactions in Burkitt's lymphoma with 8;14 translocations.
Shiramizu B; Magrath I
Blood; 1990 May; 75(9):1848-52. PubMed ID: 2110009
[TBL] [Abstract][Full Text] [Related]
20. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
Erisman MD; Scott JK; Watt RA; Astrin SM
Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
